Form 4: MBX Biosciences Executive Sells Shares
Insider Transaction (Form 4)
Salomon Azoulay, Chief Medical Officer of MBX Biosciences, Inc., sold 370 shares of common stock on August 4, 2026 for $65.77 per share.
Summary
- Open-market sale: disposed of 370 Common Stock at $65.77 ($24,335) on August 4, 2026; holds 14,399 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $24,335 of stock on the open market.
Insider Transactions
Salomon Azoulay — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-04 | Open-market sale | Common Stock | 370 | $66 | $24.3K | 14,399 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-04 | Open-market sale (370 shares) |
Keywords
insider transaction, Form 4, MBX, MBX Biosciences, Inc., bearish, Salomon Azoulay
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.